Skip to main content

Research Repository

Advanced Search

Stromal lymphocytes are associated with upgrade of B3 breast lesions

Kader, Tanjina; Provenzano, Elena; Jayawardana, Madawa W; Hendry, Shona; Pang, Jia-Ming; Elder, Kenneth; Byrne, David J; Tjoeka, Lauren; Frazer, Helen Ml; House, Eloise; Jayasinghe, Sureshni I; Keane, Holly; Murugasu, Anand; Rajan, Neeha; Miligy, Islam; Toss, Michael; Green, Andrew; Rakha, Emad; Fox, Stephen B; Mann, Bruce; Campbell, Ian G; Gorringe, Kylie L

Stromal lymphocytes are associated with upgrade of B3 breast lesions Thumbnail


Authors

Tanjina Kader

Elena Provenzano

Madawa W Jayawardana

Shona Hendry

Jia-Ming Pang

Kenneth Elder

David J Byrne

Lauren Tjoeka

Helen Ml Frazer

Eloise House

Sureshni I Jayasinghe

Holly Keane

Anand Murugasu

Neeha Rajan

Islam Miligy

Michael Toss

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology

Stephen B Fox

Bruce Mann

Ian G Campbell

Kylie L Gorringe



Abstract

Various histopathological, clinical and imaging parameters have been evaluated to identify a subset of women diagnosed with lesions with uncertain malignant potential (B3 or BIRADS 3/4A lesions) who could safely be observed rather than being treated with surgical excision, with little impact on clinical practice. The primary reason for surgery is to rule out an upgrade to either ductal carcinoma in situ or invasive breast cancer, which occurs in up to 30% of patients. We hypothesised that the stromal immune microenvironment could indicate the presence of carcinoma associated with a ductal B3 lesion and that this could be detected in biopsies by counting lymphocytes as a predictive biomarker for upgrade. A higher number of lymphocytes in the surrounding specialised stroma was observed in upgraded ductal and papillary B3 lesions than non-upgraded (p < 0.01, negative binomial model, n = 307). We developed a model using lymphocytes combined with age and the type of lesion, which was predictive of upgrade with an area under the curve of 0.82 [95% confidence interval 0.77–0.87]. The model can identify some patients at risk of upgrade with high sensitivity, but with limited specificity. Assessing the tumour microenvironment including stromal lymphocytes may contribute to reducing unnecessary surgeries in the clinic, but additional predictive features are needed.

Citation

Kader, T., Provenzano, E., Jayawardana, M. W., Hendry, S., Pang, J.-M., Elder, K., Byrne, D. J., Tjoeka, L., Frazer, H. M., House, E., Jayasinghe, S. I., Keane, H., Murugasu, A., Rajan, N., Miligy, I., Toss, M., Green, A., Rakha, E., Fox, S. B., Mann, B., …Gorringe, K. L. (2024). Stromal lymphocytes are associated with upgrade of B3 breast lesions. Breast Cancer Research, 26, Article 115

Journal Article Type Article
Acceptance Date Jun 11, 2024
Online Publication Date Jul 8, 2024
Publication Date Jul 8, 2024
Deposit Date Aug 15, 2024
Publicly Available Date Aug 19, 2024
Print ISSN 1465-5411
Electronic ISSN 1465-542X
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 26
Article Number 115
Public URL https://nottingham-repository.worktribe.com/output/38379456
Publisher URL https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-024-01857-y

Files






You might also like



Downloadable Citations